Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from &szlig;-blockers and prostaglandin analogs | Zendy

Kenji Inoue | Zendy; Setogawa | Zendy; Higa | Zendy; Moriyama | Zendy; Masato Wakakura | Zendy; Tomita | Zendy

Open Access

Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from ß-blockers and prostaglandin analogs

Author(s) -

Kenji Inoue,

Setogawa,

Higa,

Moriyama,

Masato Wakakura,

Tomita

Publication year - 2012

Publication title -

clinical ophthalmology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.025

H-Index - 56

eISSN - 1177-5483

pISSN - 1177-5467

DOI - 10.2147/opth.s29062

Subject(s) - travoprost , timolol , medicine , intraocular pressure , regimen , ophthalmology , ocular hypertension , glaucoma , prostaglandin analogue , anesthesia , adverse effect , pharmacology , surgery

Travoprost 0.004%/timolol maleate 0.5% fixed combination eye drops are available in Japan. We prospectively investigated the intraocular pressure (IOP)-decreasing effect of travoprost 0.004%/timolol maleate 0.5% fixed combination eye drops and the adherence of patients to the administration protocol.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research